Titoli del Settore Sanitario
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 441 | VNDA Vanda Pharmaceuticals Inc. | 7.2700 USD | -0.68% | -0.27% | -17.10% | +31.46% | 429.72 M USD | ||
| 442 | ANGO AngioDynamics, Inc. | 10.3400 USD | -1.24% | +3.40% | -2.91% | -16.48% | 427.24 M USD | ||
| 443 | ENTA Enanta Pharmaceuticals, Inc | 14.55 USD | -0.55% | +6.44% | +13.05% | +190.42% | 422.23 M USD | ||
| 444 | RCKT Rocket Pharmaceuticals, Inc. Common Stock | 3.88 USD | +6.59% | +9.30% | -19.50% | -39.38% | 421.25 M USD | ||
| 445 | AKBA Akebia Therapeutics, Inc. | 1.5500 USD | -0.64% | +9.15% | +4.73% | +31.36% | 415.21 M USD | ||
| 446 | CLYM Climb Bio, Inc. Common Stock | 8.6500 USD | -2.26% | +22.00% | +22.35% | +58.14% | 413.19 M USD | ||
| 447 | NAUT Nautilus Biotechnolgy, Inc. Common Stock | 3.25 USD | +6.21% | +4.17% | +37.71% | +322.08% | 411.33 M USD | ||
| 448 | LCTX Lineage Cell Therapeutics, Inc. | 1.6350 USD | +2.83% | +6.17% | +4.14% | -4.78% | 407.26 M USD | ||
| 449 | NRC National Research Corporation Common Stock (Delaware) | 17.84 USD | +4.69% | +3.48% | +8.52% | +65.03% | 405.80 M USD | ||
| 450 | AUTL Autolus Therapeutics plc American Depositary Share | 1.49 USD | +0.68% | 0.00% | +2.76% | +5.67% | 396.55 M USD | ||
| 451 | XFOR X4 Pharmaceuticals, Inc. Common Stock | 4.3300 USD | +3.10% | +7.71% | +18.96% | +45.79% | 393.68 M USD | ||
| 452 | CERS Cerus Corp | 2.02 USD | +0.50% | +7.45% | +19.53% | +53.03% | 388.19 M USD | ||
| 453 | PALI Palisade Bio, Inc. Common Stock | 2.3400 USD | +13.59% | +24.47% | +19.39% | +37.65% | 388.17 M USD | ||
| 454 | MNPR Monopar Therapeutics Inc. Common Stock | 57.9100 USD | -0.02% | +1.01% | -4.07% | +6.02% | 387.54 M USD | ||
| 455 | LAB Standard BioTools Inc. Common Stock | 0.98 USD | +10.11% | +3.16% | +5.38% | -14.78% | 382.27 M USD | ||
| 456 | DCTH Delcath Systems Inc | 10.9900 USD | +1.01% | +12.72% | +14.60% | +6.29% | 381.86 M USD | ||
| 457 | PBYI PUMA BIOTECHNOLOGY INC | 7.48 USD | -1.19% | +0.81% | +24.67% | +154.42% | 380.56 M USD | ||
| 458 | ZNTL Zentalis Pharmaceuticals, Inc. Common Stock | 5.36 USD | +3.28% | +77.48% | +94.91% | +325.40% | 380.19 M USD | ||
| 459 | NAGE Niagen Bioscience, Inc. Common Stock | 4.7400 USD | +1.07% | +4.64% | -1.66% | -4.82% | 379.58 M USD | ||
| 460 | CABA Cabaletta Bio, Inc. Common Stock | 3.40 USD | +4.29% | +10.75% | +9.32% | +200.88% | 378.50 M USD |
Notizie Titoli del Settore Sanitario
BofA alza il target su Hims and Hers per opzionalità sui peptidi
Universal Health Services Is A Huge Bargain At 8x Earnings Vs HCA At 16x (NYSE:UHS)
BofA alza il target su Ascendis Pharma per le vendite di Yorvipath
Precision BioSciences, Inc. (DTIL) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
Humana dichiara un dividendo trimestrale di 0,885 dollari per azione
Leerink conferma rating Outperform su Structure Therapeutics
CareDx vende la divisione prodotti da laboratorio per 170 milioni di dollari in contanti
Gainers Titoli del Settore Sanitario
IMMP Immutep Limited American Depositary Shares | 0.54 | +74.19% |
CUE Cue Biopharma, Inc. | 0.72 | +63.64% |
NOTV Inotiv, Inc. Common Stock | 0.39 | +56.00% |
NIVFW NewGenIvf Group Limited Class A ordinary shares | 0.0194 | +45.86% |
CDTTW CDT Equity Inc. Common Stock | 0.0085 | +41.67% |
NXGL NexGel, Inc Common Stock | 0.76 | +28.81% |
PDSB PDS Biotechnology Corporation Common Stock | 1.36 | +28.30% |
TSHA Taysha Gene Therapies, Inc. Common Stock | 6.00 | +27.39% |
Losers Titoli del Settore Sanitario
WORX SC WORX Corp | 1.06 | -30.72% |
CMND Clearmind Medicine Inc. Common Shares | 0.65 | -28.57% |
BEAT Heartbeam, Inc. Common Stock | 0.89 | -25.83% |
TALKW Talkspace, Inc. Common Stock | 0.0016 | -23.81% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0796 | -20.32% |
JSPRW Jasper Therapeutics, Inc. Common Stock | 0.0166 | -20.19% |
TOIIW The Oncology Institute, Inc. Common Stock | 0.0399 | -18.40% |
ONCO Onconetix, Inc. Common Stock | 0.7615 | -16.32% |